Treatment strategy for small hepatocellular carcinoma: comparison of long-term results after percutaneous ethanol injection therapy and surgical resection.
about
Percutaneous ethanol injection or percutaneous acetic acid injection for early hepatocellular carcinomaPercutanous ethanol injection or percutaneous acetic acid injection for early hepatocellular carcinomaA prospective randomized trial comparing percutaneous local ablative therapy and partial hepatectomy for small hepatocellular carcinomaRole of local ablative therapy for hepatocellular carcinomaExperimental and clinical assessment of percutaneous hepatic quantified ethanol injection in treatment of hepatic carcinoma.Laparoscopic liver resection for peripheral hepatocellular carcinoma in patients with chronic liver disease: midterm results and perspectives.Thermal ablation of hepatocellular carcinoma.Percutaneous ablation for small hepatocellular carcinoma.Combination of repeated single-session percutaneous ethanol injection and transarterial chemoembolisation compared to repeated single-session percutaneous ethanol injection in patients with non-resectable hepatocellular carcinoma.Percutaneous ablation of hepatic tumors.Prognostic prediction and treatment strategy in hepatocellular carcinoma.Initial response to percutaneous ablation predicts survival in patients with hepatocellular carcinoma.Surgery for hepatocellular carcinoma.Treatment of non-resectable hepatocellular carcinoma.Evidence-based medicine in the treatment of hepatocellular carcinoma.Management of small hepatocellular carcinoma: a review of transplantation, resection, and ablation.Comparison of tissue pressure and ablation time between the LeVeen and cool-tip needle methods.Ultrasound guided fine needle biopsy of early hepatocellular carcinoma complicating liver cirrhosis: a multicentre studyLong acting octreotide in the treatment of advanced hepatocellular cancer and overexpression of somatostatin receptors: randomized placebo-controlled trial.Local recurrence is an important prognostic factor of hepatocellular carcinoma.Diagnostic biopsy for hepatocellular carcinoma in cirrhosis: useful, necessary, dangerous, or academic sport?Experimental study on ultrasound-guided intratumoral injection of "Star-99" in treatment of hepatocellular carcinoma of nude miceFerucarbotran versus Gd-DTPA-enhanced MR imaging in the detection of focal hepatic lesions.Anticancer effects of bufalin on human hepatocellular carcinoma HepG2 cells: roles of apoptosis and autophagy.Identification of an H2-Kb or H2-Db restricted and glypican-3-derived cytotoxic T-lymphocyte epitope peptide.New perspectives and strategy research biomarkers for hepatocellular carcinoma.Long-term results of percutaneous ethanol injection for the treatment of hepatocellular carcinoma in KoreaRelationship between microvessel count and post-hepatectomy survival in patients with hepatocellular carcinoma.Evidence-based diagnosis and locoregional therapy for hepatocellular carcinoma.Preoperative radiologic and postoperative pathologic risk factors for early intra-hepatic recurrence in hepatocellular carcinoma patients who underwent curative resection.Liver transplantation for hepatocellular carcinoma: single nodule with Child-Pugh class A sized less than 3 cm.Overexpression of Rab25 promotes hepatocellular carcinoma cell proliferation and invasion.Overexpression of Rab5a promotes hepatocellular carcinoma cell proliferation and invasion via FAK signaling pathway.Overexpression of SPAG9 correlates with poor prognosis and tumor progression in hepatocellular carcinoma.Rsf-1 overexpression serves as a prognostic marker in human hepatocellular carcinoma.Artificial neural networking model for the prediction of post-hepatectomy survival of patients with early hepatocellular carcinoma.Image-guided thermal ablation of nonresectable hepatic tumors using the Cool-Tip radiofrequency ablation system.Assessment of Hepatocellular Carcinoma Metastasis Glycobiomarkers Using Advanced Quantitative N-glycoproteome Analysis.Long-term outcome after liver resection and clinicopathological features in patients with small hepatocellular carcinoma.A long-term follow-up and comprehensive observation of risk and prognosis factors of recurrence and survival after resection of hepatocellular carcinoma.
P2860
Q24186496-1838BEB1-BBB9-4F62-A41C-7B18B4AFBC1CQ24240216-31D4690B-662B-4F04-B181-2FC946A2F2A9Q24544663-34B67921-AB10-4808-BA69-623CE0C864C5Q30417048-6C723F05-DE79-46CE-BB00-CA1C7C2E063EQ31117645-71C13876-299C-4FE0-92F7-4E581E98DDA5Q33237223-D783BC95-C98A-4400-AAF8-8886C2174A80Q33323261-40182887-448B-4BEA-A2FE-004337AA38AFQ33427579-992FB13F-A5FD-4AC2-A213-F487E52F1624Q33866389-8D8294B3-7FB0-4182-88B5-1F9596AE8953Q34253356-C2EF25F6-C9B6-4408-8357-F494DB15C00BQ34547469-0BF38FB7-1035-4FA9-81D4-F4AD60589CF6Q34552875-2ABA0959-1E9D-4196-B608-61E8D1F9261BQ35020882-A2C1AC55-A4DC-41FF-9923-54F2BDA22D12Q35020886-D8170737-9765-4F87-9E6F-F514E2545595Q35020890-FD5F3EB8-5C6A-43EA-ACEA-18963441709FQ35081063-71136AC2-0C8F-4A0C-AF00-B0C602628795Q35574968-F9F570D4-9165-4717-9E17-FD0510422589Q35596794-0095592D-FED9-49FA-BA31-CBDB90ACE14FQ35621231-CF397742-D1E4-46DC-A917-38A8DE298EE2Q35784062-E9ADA656-0EC1-4061-BEED-6A36E5E1D2DEQ35861149-9EA35DD5-7777-4339-8791-D23DE480CE0FQ36178649-AA9F9F80-345A-4740-A1F5-CF6BCE40CF13Q36179721-7BEC2551-3E0B-4515-9693-5EB965DD6B3BQ36590051-EEDAD09F-AB0E-4861-9F5F-A244EDA4335CQ36684407-9CA0DB94-6B6F-4159-B429-BD52431969FEQ36883798-E9A5ADA8-3224-4189-8D0D-214B442D6BB5Q37155074-8853E98C-A397-4C88-88C0-7B84F61E34D4Q37338042-C181855C-F7AB-4BAF-B63A-CC35CFEE2ED6Q37353089-1DAE362D-66B5-4F74-ABC4-8A35D0441F8FQ37485623-BB87ADD4-23EA-40E9-8580-7902FFBB2626Q38503860-F06EFC98-1013-4E81-8532-3380FDC0D534Q38809899-75B0CD9E-4F77-437E-B93D-BDC32176BF96Q38829853-555AA1BF-4B06-4551-9E5A-B51678EB4C45Q38997891-DBBE8018-BD4F-4373-BC5F-3DCE39A742A7Q38998210-BD6DEA9A-8CF5-4FB6-978E-61B74D778B8AQ39165780-C023E8F7-7993-46B2-9B82-DE1F6FB9FE59Q40150833-D5F98A0C-8758-48EF-9FBB-E8A887E6DE39Q40955052-CDF07A58-C850-4BA3-B6CF-1B53404B691EQ42164576-1EBE1FB7-EDF5-4EAE-9A32-8C66610D188AQ42224788-C7E57C5B-A9E3-4A19-858F-47182945FD55
P2860
Treatment strategy for small hepatocellular carcinoma: comparison of long-term results after percutaneous ethanol injection therapy and surgical resection.
description
2001 nî lūn-bûn
@nan
2001 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Treatment strategy for small h ...... herapy and surgical resection.
@ast
Treatment strategy for small h ...... herapy and surgical resection.
@en
Treatment strategy for small h ...... herapy and surgical resection.
@nl
type
label
Treatment strategy for small h ...... herapy and surgical resection.
@ast
Treatment strategy for small h ...... herapy and surgical resection.
@en
Treatment strategy for small h ...... herapy and surgical resection.
@nl
prefLabel
Treatment strategy for small h ...... herapy and surgical resection.
@ast
Treatment strategy for small h ...... herapy and surgical resection.
@en
Treatment strategy for small h ...... herapy and surgical resection.
@nl
P2093
P356
P1433
P1476
Treatment strategy for small h ...... herapy and surgical resection.
@en
P2093
Yamamoto J
Yamasaki S
P304
P356
10.1053/JHEP.2001.27950
P407
P433
P577
2001-10-01T00:00:00Z